IPOOculis lists at Nasdaq through SPAC mergerLatest NewsThe eye disease specialist Oculis Holding AG has been listed on Nasdaq following the merger of Oculis SA with European Biotech Acquisition Corp. Read more 5 March 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2023-03-06_um_15.49.27.png 372 847 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-03-05 18:52:392024-07-12 12:59:46Oculis lists at Nasdaq through SPAC merger